Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

IMAC


Top 10 Correlated ETFs

IMAC


Top 10 Correlated Stocks

IMAC


In the News

11:04 03 Oct 2022 IMAC

Best Penny Stocks To Buy? Einhorn, Lynch, Cohen & Dalio Own These 5

Top Wall Street Investors Own These 5 Penny Stocks. Are They A Buy Now?

09:59 03 Oct 2022 IMAC

Legendary Investor Peter Lynch Just Bet on IMAC Stock. 9 Things to Know.

IMAC stock is soaring higher today on news that legendary investor Peter Lynch has taken a stake in little-known IMAC Holdings. The post Legendary Investor Peter Lynch Just Bet on IMAC Stock.

02:32 03 Oct 2022 IMAC

Time to Take Profits on IMAC Stock After Shares Soar on Walmart News

It is time to sell your IMAC stock and make a nice profit on the recent rally because the company hasn't shown the ability to make profits. The post Time to Take Profits on IMAC Stock After Shares Soar on Walmart News appeared first on InvestorPlace.

04:07 03 Oct 2022 IMAC

Best Reddit Penny Stocks To Buy Now? 5 Trending Stocks To Watch Today

What are the best penny stocks to buy today? The post Best Reddit Penny Stocks To Buy Now?

04:04 03 Oct 2022 IMAC

Will IMAC Holdings, Inc. (IMAC) Report Negative Q2 Earnings? What You Should Know

IMAC Holdings, Inc. (IMAC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

06:01 03 Oct 2022 IMAC

IMAC Holdings to Present at the Summer Solstice - Best Ideas from the Buy Side Conference on Tuesday, June 1, 2021

Brentwood, Tenn, May 26, 2021 (GLOBE NEWSWIRE) -- IMAC Holdin gs, Inc. (Nasdaq: IMAC, IMACW), a provider of innovative medical advancements and care specializing in regenerative and rehabilitation orthopedic treatments without the use of surgery or opioids, announced today that management has been invited to present at the Summer Solstice - Best Ideas from the Buy Side Conference, which is being held virtually on June 1 – June 4, 2021.

05:50 03 Oct 2022 IMAC

IMAC Holdings Announces Pricing of its Public Offering of Common Stock

Brentwood, Tenn, March 23, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (the “Company” or “IMAC”) (Nasdaq: IMAC, IMACW), a provider of innovative medical advancements and care specializing in regenerative and rehabilitation orthopedic treatments without the use of surgery or opioids, announced today the pricing of its underwritten registered public offering of 10,625,000 shares of its common stock at a public offering price of $1.60 per share, for total gross proceeds of $17.0 million. The net proceeds, after underwriting discounts, but before estimated expenses of the offering payable by IMAC, are expected to be approximately $16.0 million. All shares of common stock to be sold in the offering will be sold by the Company, except that the Company, together with its co-founder and chief operating officer as a selling stockholder, will grant the underwriter for the offering a 45-day option to purchase up to 15% of the shares of common stock in the offering. The offering is expected to close on or about March 26, 2021, subject to the satisfaction of customary closing conditions.

09:00 03 Oct 2022 IMAC

IMAC Holdings Reports 2020 Financial Results and Corporate Update

BRENTWOOD, Tenn., March 04, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced financial results for the year ended December 31, 2020.

09:25 03 Oct 2022 IMAC

IMAC Holdings, Inc. Announces Completion of First Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson's Disease

BRENTWOOD, Tenn, March 01, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has completed the first cohort of its Phase 1 clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinson's disease.

09:00 03 Oct 2022 IMAC

IMAC Holdings Adds Regenerative Wound Care Service in Regeneration Centers

Insurance to Reimburse Services Providing Cell-Based Amniotic-Infused Mesh Application to Chronic Non-Healing Wounds and Diabetic Foot Ulcers

Financial details

Company Rating
Buy
Market Cap
26.75M
Income
-11.71M
Revenue
15.22M
Book val./share
0.59
Cash/share
0.17
Dividend
-
Dividend %
-
Employees
154
Optionable
No
Shortable
Yes
Earnings
15 Aug 2022
P/E
-2.18
Forward P/E
-
PEG
-9.81
P/S
1.68
P/B
1.71
P/C
2.23
P/FCF
-2.82
Quick Ratio
1.15
Current Ratio
1.27
Debt / Equity
0.25
LT Debt / Equity
0.25
-
-
EPS (TTM)
-0.46
EPS next Y
-
EPS next Q
-
EPS this Y
111.11%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
159.97%
Revenue last 5Y
78.85%
Revenue Q/Q
-10.84%
EPS Q/Q
-36.84%
-
-
-
-
SMA20
-14.29%
SMA50
-58.42%
SMA100
-48.78%
Inst Own
20.39%
Inst Trans
0.9%
ROA
-48%
ROE
-57%
ROC
-0.44%
Gross Margin
42%
Oper. Margin
-55%
Profit Margin
-77%
Payout
-
Shs Outstand
26.49M
Shs Float
18.2M
-
-
-
-
Target Price
-
52W Range
0.58-1.65
52W High
-
52W Low
-
RSI
24.87
Rel Volume
0.09
Avg Volume
892.34K
Volume
76.2K
Perf Week
-17.03%
Perf Month
-37.1%
Perf Quarter
-60.48%
Perf Half Y
-63.9%
-
-
-
-
Beta
-0.885873
-
-
Volatility
0.03%, 0.05%
Prev Close
0.58%
Price
0.379
Change
-1.84%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2019-12-312020-12-31 2021-12-31
Revenue per share
1.951.161.3
Net income per share
-0.84-0.5-0.95
Operating cash flow per share
-0.52-0.54-0.69
Free cash flow per share
-0.68-0.55-0.75
Cash per share
0.050.240.64
Book value per share
1.290.941.62
Tangible book value per share
-0.16-0.490.68
Share holders equity per share
1.290.941.62
Interest debt per share
0.720.380.58
Market cap
9.15M18.56M14.37M
Enterprise value
13.43M19.56M13.15M
P/E ratio
-1.41-3.35-1.36
Price to sales ratio
0.61.451
POCF ratio
-2.25-3.1-1.89
PFCF ratio
-1.74-3.03-1.73
P/B Ratio
0.911.780.8
PTB ratio
0.911.780.8
EV to sales
0.891.520.91
Enterprise value over EBITDA
-3.32-6.01-1.57
EV to operating cash flow
-3.3-3.26-1.73
EV to free cash flow
-2.55-3.2-1.59
Earnings yield
-0.71-0.3-0.73
Free cash flow yield
-0.58-0.33-0.58
Debt to equity
0.2100.23
Debt to assets
0.610.790.34
Net debt to EBITDA
-1.06-0.310.14
Current ratio
0.420.81.84
Interest coverage
-6.89-11.50
Income quality
0.631.080.72
Dividend Yield
000
Payout ratio
000
Sales general and administrative to revenue
1.060.360.45
Research and developement to revenue
000
Intangibles to total assets
0.450.570.38
Capex to operating cash flow
0.290.020.09
Capex to revenue
-0.08-0.01-0.05
Capex to depreciation
-0.77-0.07-0.42
Stock based compensation to revenue
0.030.030.04
Graham number
4.943.265.91
ROIC
-0.43-0.70
Return on tangible assets
-0.58-0.85-0.63
Graham Net
-1.44-0.74-0.11
Working capital
-3.49M-1.19M4.13M
Tangible asset value
-1.27M-5.4M7.49M
Net current asset value
-9.9M-7.18M-208.63K
Invested capital
0.460.350.33
Average receivables
1.39M1.51M1.36M
Average payables
2.3M1.69M0
Average inventory
000
Days sales outstanding
30.3643.0530.68
Days payables outstanding
418.0700
Days of inventory on hand
000
Receivables turnover
12.028.4811.9
Payables turnover
0.8700
Inventory turnover
000
ROE
-0.65-0.53-0.59
Capex per share
-0.15-0.01-0.06

Quarterly Fundamentals Overview

Last date of statement is 2022-03-31 for Q1

Metric History 2021-03-312021-06-302021-09-302021-12-31 2022-03-31
Revenue per share
0.230.140.140.170.15
Net income per share
-0.15-0.08-0.07-0.19-0.12
Operating cash flow per share
-0.13-0.1-0.06-0.07-0.1
Free cash flow per share
-0.14-0.11-0.06-0.08-0.11
Cash per share
1.160.540.440.280.17
Book value per share
1.911.030.950.710.59
Tangible book value per share
1.040.540.440.30.19
Share holders equity per share
1.911.030.950.710.59
Interest debt per share
0.570.310.270.240.21
Market cap
22.19M49.78M37.48M28.87M26.08M
Enterprise value
14.11M43.95M32.98M27.65M27.19M
P/E ratio
-2.79-6.24-5.44-1.49-2.06
Price to sales ratio
7.2414.3710.756.616.7
POCF ratio
-12.68-19.29-26.57-15.61-10.67
PFCF ratio
-11.86-17.99-24.31-13.71-9.8
P/B Ratio
0.861.931.561.611.74
PTB ratio
0.861.931.561.611.74
EV to sales
4.6112.689.466.336.98
Enterprise value over EBITDA
-10.14-30.78-28.39-6.27-10.03
EV to operating cash flow
-8.06-17.03-23.38-14.95-11.13
EV to free cash flow
-7.54-15.88-21.4-13.13-10.21
Earnings yield
-0.09-0.04-0.05-0.17-0.12
Free cash flow yield
-0.08-0.06-0.04-0.07-0.1
Debt to equity
0.150.170.170.230.25
Debt to assets
0.320.310.330.340.38
Net debt to EBITDA
5.814.083.870.28-0.41
Current ratio
2.772.992.521.841.27
Interest coverage
-11.62-19.11-25.730-761.27
Income quality
0.881.290.820.380.77
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
1.331.381.48-1.740.47
Research and developement to revenue
00000
Intangibles to total assets
0.260.270.290.380.42
Capex to operating cash flow
0.070.070.090.140.09
Capex to revenue
-0.04-0.05-0.04-0.06-0.06
Capex to depreciation
-0.29-0.42-0.29-0.77-0.49
Stock based compensation to revenue
0.040.040.050.030.05
Graham number
2.521.351.211.751.29
ROIC
-0.08-0.09-0.120-0.17
Return on tangible assets
-0.08-0.08-0.08-0.29-0.23
Graham Net
0.460.180.1-0.05-0.14
Working capital
11.7M10.82M8.18M4.13M1.44M
Tangible asset value
13.97M13.62M11.02M7.49M4.76M
Net current asset value
7.5M6.11M3.91M-208.63K-2.55M
Invested capital
0.290.30.280.330.36
Average receivables
1.53M1.27M1.18M1.21M1.47M
Average payables
00000
Average inventory
00000
Days sales outstanding
54.2234.8129.8224.9139.86
Days payables outstanding
000073.2
Days of inventory on hand
00000
Receivables turnover
1.662.593.023.612.26
Payables turnover
00001.23
Inventory turnover
00000
ROE
-0.08-0.08-0.07-0.27-0.21
Capex per share
-0.01-0.01-0.01-0.01-0.01

Frequently Asked Questions

What is IMAC Holdings, Inc. stock symbol ?

IMAC Holdings, Inc. is a US stock , located in Brentwood of Tennessee and trading under the symbol IMAC

What is IMAC Holdings, Inc. stock quote today ?

IMAC Holdings, Inc. stock price is $0.379 today.

Is IMAC Holdings, Inc. stock public?

Yes, IMAC Holdings, Inc. is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap